Approval · Notice of Compliance 12366 · 2011
THYROGEN: Notice of Compliance 12366
Issued May 25, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12366
- Date
- May 25, 2011
- Company
- Genzyme Canada Inc
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing facility
- Therapeutic class
- Thyroid stimulating hormone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| THYROGEN | Not yet assigned | — |
Medicinal ingredients
- THYROTROPIN ALFA 0.9 MG per ML